Prosecution Insights
Last updated: November 04, 2026

Hdr LLC

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Hdr LLC has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to MAEWALL, SNIGDHA, the only distinct examiner for the portfolio. With 1 distinct art unit involved, the current prosecution is limited to this single interaction. This concentration means that the company's current success at the USPTO relies on the specific interpretation and feedback of a single official.

The busiest examiner, MAEWALL, SNIGDHA, is responsible for 1 pending office action, which represents the full extent of the company's current active docket. This one-to-one relationship between the examiner and the pending action count simplifies the management of the portfolio but increases the impact of that single examiner's decisions. Practitioners should focus on the specific preferences and historical trends of this individual examiner within the Biotechnology & Pharmaceuticals field.

Because there is only 1 distinct art unit, the technology is likely specialized within the biological domain. The absence of other pending actions or distinct examiners means there are no alternative prosecution paths currently active to offset any challenges encountered with this single application. This focused profile requires a precise and well-supported response to the 1 pending office action currently on record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting + other1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MAEWALL, SNIGDHA 1 58.8% +10.7%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18967485 ANTIMICROBIAL COMPOSITION AND SYSTEM FOR DELIVERING AN ANTIMICROBIAL COMPOSITION MAEWALL, SNIGDHA —

Top Art Units

Art UnitApps
1612 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18967485 ANTIMICROBIAL COMPOSITION AND SYSTEM FOR DELIVERING AN ANTIMICROBIAL COMPOSITION MAEWALL, SNIGDHA 1612 §103DP Non-Final OA — Pending Dec 03, 2024

Managing Hdr LLC's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Hdr LLC have?

Hdr LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Hdr LLC applications?

Snigdha Maewall has the most, with 1 of Hdr LLC's pending office actions.

What technology area are Hdr LLC's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month